Dr. Refaya Rezwan is an Assistant Professor in the Department of Pharmacy at United International University. Her academic and research background spans pharmaceutical sciences, nanomedicine, and innate immunity. She has recently completed her Ph.D. in Translational Sciences (Immunology) at Monash University, Australia, under the supervision of Associate Professor Michael P. Gantier. Her doctoral research, currently under review, focused on the characterization of novel inhibitors of DNA-sensing immune pathways.

Dr. Rezwan holds an Erasmus Mundus Joint Master’s Degree in Nanomedicine for Drug Delivery from Université Paris Cité and the University of Angers, France, and completed both her Bachelor of Pharmacy (B.Pharm, Hons.) and Master of Pharmacy (M.Pharm) in Pharmaceutical Chemistry at the University of Dhaka, Bangladesh. Her research integrates molecular immunology and advanced drug delivery systems, with particular interest in innate immune signaling, nucleic acid sensing, and nanoparticle-based therapeutics.

She has co-authored multiple peer-reviewed publications in leading international journals, including Nature Communications, RSC Advances, and Molecules, and has presented her work at major scientific conferences across Europe, Australia, and the United States. Dr. Rezwan is a recipient of several prestigious awards and fellowships, including the Erasmus+ Scholarship, Monash Graduate Scholarship, and the RNA Society Research Presentation Fellowship.

Her current academic focus includes pharmaceutical technology, medicinal chemistry, and pathology, while continuing research in immunomodulatory drug discovery and nanotherapeutics.

1. Alharbi AS, Sapkota S, Zhang Z,… Rezwan R, et al. 2’-O-Methyl-guanosine 3-base RNA fragments mediate essential natural TLR7/8 antagonism. bioRxiv. Published online July 25, 2024:2024.07.25.605091. doi:10.1101/2024.07.25.605091
2. Ullah TR, Johansen MD, Balka KR,… Rezwan R, et al. Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection. Nat Commun 2023 141. 2023;14(1):1-13. doi:10.1038/s41467-023-41381-9
3. Tajnur R, Rezwan R, Aziz A, Islam MS. An update on vaccine status and the role of nanomedicine against SARS-CoV-2: A narrative review. Heal Sci Reports. 2023;6(7):e1377. doi:10.1002/HSR2.1377
4. Matthew SAL, Rezwan R, Perrie Y, Seib FP. Volumetric Scalability of Microfluidic and Semi-Batch Silk Nanoprecipitation Methods. Molecules. 2022;27(7). doi:10.3390/molecules27072368
5. Matthew SAL, Rezwan R, Kaewchuchuen J, Perrie Y, Seib FP. Mixing and flow-induced nanoprecipitation for morphology control of silk fibroin self-assembly. RSC Adv. 2022;12(12):7357-7373. doi:10.1039/d1ra07764c
6. Thipe VC, Karikachery AR, Çakılkaya P,…Rezwan R, et al. Green nanotechnology—An innovative pathway towards biocompatible and medically relevant gold nanoparticles. J Drug Deliv Sci Technol. 2022;70. doi:10.1016/j.jddst.2022.103256
7. Bavaro T, Tengattini S, Rezwan R, et al. Design of epidermal growth factor immobilization on 3D biocompatible scaffolds to promote tissue repair and regeneration. Sci Rep. 2021;11(1):1-13. doi:10.1038/s41598-021-81905-1
8. Begum K, Mannan SJ, Rezwan R, Rahman MM, Rahman MS, Kamal ANE. Isolation and Characterization of Bacteria with Biochemical and Pharmacological Importance from Soil Samples of Dhaka City. Dhaka Univ J Pharm Sci. 2017;16(1):129-136. doi:10.3329/dujps.v16i1.33390
9. Mannan SJ, Rezwan R, Rahman MS, Begum K. Isolation and Biochemical Characterization of Lactobacillus species from Yogurt and Cheese samples in Dhaka Metropolitan Area. Bangladesh Pharm J. 2017;20(1):27-33. doi:10.3329/bpj.v20i1.32090

Full list of Publications can be found on Orchid.